BIEFFE MEDITAL SPA
Simtra BioPharma Solutions Completes Major Facility Expansion in Germany to Meet Growing Injectable Therapeutics Demand
Simtra BioPharma Solutions has completed construction of a new 1,800 square meter production facility at its Halle, Germany campus, expanding total production area to nearly 12,000 square meters.
Basil Systems Secures $11.5M to Revolutionize Life Sciences Decision-Making with AI
ā¢ Basil Systems has raised $11.5 million in funding led by Golden Ventures, with participation from Hearst Ventures and Argosy Capital, to expand its AI-powered product lifecycle intelligence platform. ā¢ The company has built BasilLink, the largest indexed dataset in life sciences with over 600 million records, providing real-time insights for regulatory submissions, clinical planning, and post-market surveillance. ā¢ Already utilized by four of the five largest global medical device companies and in trials with major pharmaceutical firms, Basil's platform aims to transform fragmented regulatory and clinical data into actionable intelligence.
Drug Shortages Crisis: Causes, Impacts, and Solutions in the US Healthcare System
Drug shortages in the US reached 323 active cases in early 2024, with 48% of shortages persisting since 2022, affecting critical medications including chemotherapies, antimicrobials, and IV fluids.
Brain Hemorrhage Treatment Market Expected to Grow Significantly by 2032 as AI Solutions Gain FDA Approval
The brain hemorrhage treatment market is projected to experience substantial growth through 2032, driven by an aging population and increasing prevalence of risk factors such as hypertension and traumatic brain injuries.
Spectral Medical's Tigris Trial Nears Completion with Strong Enrollment
Spectral Medical's Tigris trial, evaluating Polymyxin B Hemoperfusion (PMX) for endotoxemia and septic shock, has enrolled 146 patients, showing strong progress.
University of Chicago's DFI to Commence Clinical Trials on Gut Microbiome Restoration
The Duchossois Family Institute (DFI) at UChicago is set to begin clinical trials in January to investigate rebuilding the gut microbiome in compromised patients.
Hurricane Helene Disrupts Spectral Medical's Sepsis Trial Enrollment
Spectral Medical faces enrollment delays in its pivotal Tigris trial for Toraymyxin due to supply chain disruptions exacerbated by Hurricane Helene.
Spectral Medical's Tigris Trial Enrollment Reaches 136 Amidst Supply Chain Hurdles
Spectral Medical's Tigris trial, evaluating PMX for endotoxemia and septic shock, has enrolled 136 patients as of November 2024.
Critical Drug Shortages Persist in US: ADHD Medications, Chemotherapy Drugs, and Insulin Among Most Affected
US drug shortages have decreased from a peak of 323 to 277 as of September 2024, though 50% of these shortages have persisted for two or more years, significantly impacting essential medications.
FDA Declares IV Fluid Shortage Following Hurricane Impact on Baxter Facilities
The FDA has added three critical intravenous solutions - Dextrose 70%, Lactated Ringers, and Peritoneal Dialysis Solution - to its Drug Shortage Database following Hurricane Helene's impact on Baxter's manufacturing facilities.